Effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis. A randomised, double blind, placebo-controlled, parallel group, single-centre trial
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Osteoarthritis
- Focus Therapeutic Use
- Acronyms LOSEIT
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.
- 16 Sep 2016 Status changed from recruiting to not yet recruiting.
- 22 Jul 2016 New trial record